ARG1 and neoplasm: Triptolide selectively inhibited macrophage differentiation toward the M2 phenotype through downregulation of CD206, arginase 1, and CD204, secretion of anti-inflammatory cytokines, and abolished M2 macrophage-mediated tumor progression [190].